Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin LymphomaSomya Khare, Eneida R. Nemecek, Peter Ferreira-Gandolfo et al.|Clinical Lymphoma Myeloma & Leukemia|2024Cited by 6
Access to Chimeric Antigen T-Cell Receptor (CAR-T) Therapies for Patients with Non-Hodgkin Lymphoma (NHL) in the Catchment Area of OregonSomya Khare, Eneida R. Nemecek, Staci Williamson et al.|Blood|2023Cited by 0
Access to chimeric antigen T-cell receptor (CAR-T) therapy for patients with Non-Hodgkin Lymphoma (NHL) in OregonSomya Khare, Eneida R. Nemecek, Staci Williamson et al.|International Journal of Cancer Care and Delivery|2023Cited by 0
Access to Allogeneic Hematopoietic Cell Transplant for Patients with Hematologic Malignancies in OregonDanielle Brouillard, Eneida R. Nemecek, Staci Williamson et al.|Transplantation and Cellular Therapy|2024Cited by 0